The global Sugar-Based Excipient Market size is expected to reach USD 1,542.5 Million by 2028 at a CAGR of 4.5%, according to the latest report by Reports and Data. Increasing use of co-processed excipients to improve dissolution, bioavailability, growth in pharmaceuticals manufacturers, surging demand and production of Orally Disintegrated Tablets (ODT), rising demand of pharmaceuticals drugs, scientific development in genetics industry, and availability of low-cost manufacturing infrastructure, and technological advancements in sugar-based excipients are some key factors expected to drive market revenue growth over the forecast period.

Excipients are the inert ingredients that are used in the manufacture of medications in order to mask the effect or bitterness of the active ingredients. The FDA has cleared the use of sugar-based excipients in paediatric medication. Cough syrups and antibiotics are two common products that contain sugar-based excipients. They are frequently employed in the disintegration of Active Pharmaceutical Ingredients (API) in sucrose, glycerol, saccharin sodium, and sorbitol. Also employed as fillers, binders, and coating materials, sugar-based excipients minimise stickiness and improve the flavour of medicines, making them much more appealing.

Request Free Sample Copy @ https://www.reportsanddata.com/download-free-sample/437

Some Key Highlights from the Report:

• Actual sugar segment is expected to account for a sizeable revenue share in the global market owing to its increased utilization in oral prescription medicines, and pediatric formulation due to its non-toxicity, and high-efficiency.
• Coatings powders/granules segment is expected to register robust revenue CAGR over the forecast period owing to increasing applications in medical pharmaceutical industries, expansion of generic medicines, and increasing pediatric population.
• Asia Pacific market revenue is expected to expand significantly over the forecast period owing to increasing growth and development in genetics field, growing healthcare and pharmaceutical industry, development in Orally Disintegrating Tablets (ODTs), and increasing government funding and investment in healthcare sector to support growth and innovation in sugar-based excipients.

Key Players covered in this report are

DFE Pharma, Archer Daniels Midland Company, Ashland Inc., Roquette Group, The Lubrizol Corporation, Associated British Foods PLC, Cargill, Inc., Colorcon Inc., FMC Corporation, and Meggle AG.

Type Outlook (Revenue, USD Billion; 2018 – 2028)

• Actual Sugars
• Sugar Alcohols
• Artificial Sweeteners

Application Outlook (Revenue, USD Billion; 2018 – 2028)

• Coatings Powders/Granules
• Direct Compression Sugars
• Crystals, Syrups

Geographic Segment Covered in the Report:

The Sugar-Based Excipients report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (USA and Canada)
• Europe (UK, Germany, France and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Sugar-Based Excipients industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Sugar-Based Excipients Market report provides key statistics on the market status of the Sugar-Based Excipients manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/437

We appreciate you reading our report. To learn more about the report and its customizable feature, please get in touch with us. Our team will make sure the report is suitable for your needs.

Get Explore Latest Research Report by Reports and Data:

http://www.ask.com/web?q=%22Oligonucleotide+Synthesis+Market+to+Exhibit+a+CAGR+of+16.8%25+for+the+Forecast+Period+to+2030%22

https://twitter.com/search/realtime?q=%22Oligonucleotide+Synthesis+Market+to+Exhibit+a+CAGR+of+16.8%25+for+the+Forecast+Period+to+2030%22

https://www.essentialhealthcarenews.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.myhealthcarereporter.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

http://www.healthcareindustrytoday.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.globalhealthcaretoday.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.ushealthcarejournal.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.medicalindustrytoday.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

http://www.todayinmedicine.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.healthcareonlinenetwork.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.healthindustrywatch.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

https://www.worldhealthcarereport.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

http://www.todayinhealthcare.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030

http://www.healthcarepressreleases.com/article/606630240-oligonucleotide-synthesis-market-to-exhibit-a-cagr-of-16-8-for-the-forecast-period-to-2030 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com